Publications by authors named "Hee-Jeong Im"

Article Synopsis
  • - The study investigates the role of periostin (POSTN) in osteoarthritis (OA), finding it is increased in patients and linked to inflammation and cartilage breakdown, suggesting it could be a target for therapy.
  • - Link N (LN), a peptide from link protein, is shown to have anabolic properties and can reduce inflammation and degradation in cartilage, leading the researchers to explore its effects on POSTN expression.
  • - Experimental results reveal that LN can decrease POSTN expression and disrupt its signaling in chondrocytes, indicating it has potential as a therapeutic agent in treating OA by targeting POSTN.
View Article and Find Full Text PDF
Article Synopsis
  • Intervertebral disc degeneration and pain are linked to the activation of the NLRP3 inflammasome and the processing of IL-1β, which involves Toll-like receptor stimulation and the CD14 receptor.
  • The peptide Short Link N (sLN) has shown promise in reducing inflammation and pain in disc cells, but its exact mechanisms of action are not fully understood.
  • This study found that sLN inhibited the activation of NFκB and Caspase-1, leading to lower levels of IL-1β, and demonstrated a direct interaction between sLN and CD14, suggesting sLN could be a potential treatment for disc-related pain.
View Article and Find Full Text PDF
Article Synopsis
  • Osteoarthritis (OA) causes pain and damage to the cartilage in joints.
  • Scientists created a special treatment called Nano-PAZII, which is a tiny particle version of an existing cancer drug that helps with OA.
  • In tests with mice, a single injection of Nano-PAZII reduced joint pain and protected cartilage without causing serious side effects.
View Article and Find Full Text PDF

Pain is the prime symptom of osteoarthritis (OA) that directly affects the quality of life. Protein kinase Cδ (PKCδ/Prkcd) plays a critical role in OA pathogenesis; however, its significance in OA-related pain is not entirely understood. The present study investigated the functional role of PKCδ in OA pain sensation.

View Article and Find Full Text PDF

The serotonin transporter (5-hydroxytryptamine transporter [5-HTT], Serotonin Transporter (SERT), SLC6A4) modulates the activity of serotonin via sodium-dependent reuptake. Given the established importance of serotonin in the control of pain, 5-HTT has received much interest in studies of pain states and as a pharmacological target for serotonin reuptake inhibitors (SRIs). Animal models expressing varying levels of 5-HTT activity show marked differences in pain behaviors and analgesic responses, as well as many serotonin-related physiological effects.

View Article and Find Full Text PDF

Chronic pain conditions create major financial and emotional burdens that can be devastating for individuals and society. One primary source of pain is arthritis, a common inflammatory disease of the joints that causes persistent pain in affected people. The main objective of pharmacological treatments for either rheumatoid arthritis (RA) or osteoarthritis (OA) is to reduce pain.

View Article and Find Full Text PDF

Pain is the major reason that patients suffering from osteoarthritis (OA) seek medical care. We found that vascular endothelial growth factors (VEGFs) mediate signaling in OA pain pathways. To determine the specific contributions of VEGFs and their receptors (VEGFRs) to joint pathology and pain transmission during OA progression, we studied intra-articular (IA) injections of VEGF ligands into murine knee joints.

View Article and Find Full Text PDF

Tropomyosin receptor kinase A (TrkA/NTRK1) is a high-affinity receptor for nerve growth factor (NGF), a potent pain mediator. NGF/TrkA signaling elevates synovial sensory neuronal distributions in the joints and causes osteoarthritis (OA) pain. We investigated the mechanisms of pain transmission as to whether peripheral sensory neurons are linked to the cellular plasticity in the dorsal root ganglia (DRG) and are critical for OA hyperalgesia.

View Article and Find Full Text PDF

The utilization of an anionic redox reaction as an innovative strategy for overcoming the limitations of cathode capacity in lithium-ion batteries has recently been the focus of intensive research. LiO-based materials using the anionic (oxygen) redox reaction have the potential to deliver a much higher capacity than commercial cathodes using cationic redox reactions based on transition-metal ions. However, parasitic reactions attributed to the superoxo species (such as LiO), derived from the LiO active material of the cathode, deteriorate the stability of the interface between the cathode and electrolyte, which has limited the commercialization of LiO-based cathodes.

View Article and Find Full Text PDF

To test probiotic therapy for osteoarthritis (OA), we administered Lactobacillus acidophilus (LA) by oral gavage (2×/week) after induction of OA by partial medial meniscectomy (PMM). Pain was assessed by von Frey filament and hot plate testing. Joint pathology and pain markers were comprehensively analyzed in knee joints, spinal cords, dorsal root ganglia and distal colon by Safranin O/fast green staining, immunofluorescence microscopy and RT-qPCR.

View Article and Find Full Text PDF

Lung cancer is the prominent cause of cancer-associated death primarily because of distant metastatic disease. The metastatic potential of non-small cell lung cancer (NSCLC) is associated with tumor cell aggregation. However, the systemic mechanotransduction mechanism by which tumor cells dynamically aggregate and disseminate is poorly understood, especially in NSCLC.

View Article and Find Full Text PDF

Lithia (LiO)-based cathodes, utilizing oxygen redox reactions for obtaining capacity, exhibit higher capacity than commercial cathodes. However, they are highly reactive owing to superoxides formed during charging, and they enable more active parasitic (side) reactions at the cathode/electrolyte and cathode/binder interfaces than conventional cathodes. This causes deterioration of the electrochemical performance limiting commercialization.

View Article and Find Full Text PDF

Osteoarthritis (OA) is one of the most common medical conditions affecting > 300 million people globally which represents the formidable public health challenge. Despite its clinical and financial ramifications, there are currently no approved disease modifying OA drugs available and symptom palliation is the only alternative. Currently, the amount of data on the human intestinal microbiome is growing at a high rate, both in health and in various pathological conditions.

View Article and Find Full Text PDF

Although degenerative disc disease (DDD) and related low back pain (LBP) are growing public health problems, the underlying disease mechanisms remain unclear. An increase in the vascular endothelial growth factor (VEGF) levels in DDD has been reported. This study aimed to examine the role of VEGF receptors (VEGFRs) in DDD, using a mouse model of DDD.

View Article and Find Full Text PDF

Osteoarthritis (OA) is a painful and debilitating disease. A striking feature of OA is the dramatic increase in vascular endothelial growth factor (VEGF) levels and in new blood vessel formation in the joints, both of which correlate with the severity of OA pain. Our aim was to determine whether anti-VEGF monoclonal antibodies (mAbs) - MF-1 (mAb to VEGFR1) and DC101 (mAb to VEGFR2) - can reduce OA pain and can do so by targeting VEGF signaling pathways such as Flt-1 (VEGFR1) and Flk-1 (VEGFR2).

View Article and Find Full Text PDF

MicroRNAs (miRNAs), small noncoding RNA molecules, have emerged as important factors during intervertebral disc degeneration. This study was to determine whether miR-202-3p regulates interleukin-1β (IL-1β)-induced expression of matrix metalloproteinase 1 (MMP-1) in human nucleus pulposus (NP) cells. Human NP cells were stimulated with IL-1β in vitro.

View Article and Find Full Text PDF

is a histone methyltransferase that suppresses osteoblast maturation and skeletal development. We evaluated the role of in chondrocyte lineage differentiation and endochondral ossification. was genetically inactivated in the mesenchymal, osteoblastic, and chondrocytic lineages in mice using the , , and drivers, respectively.

View Article and Find Full Text PDF

Background/aims: Intervertebral discs consist of an extracellular matrix (ECM) with a central gelatinous nucleus pulposus (NP) enclosed in an outer layer known as the annulus fibrosus. ECM metabolic disorders result in loss of boundary between the annulus fibrosus and NP, which can lead to intervertebral disc degeneration (IDD). Proinflammatory cytokines, such as interleukin (IL)-1β, mediate the progression of IDD.

View Article and Find Full Text PDF

Environmental disruption of the circadian rhythm is linked with increased pain due to osteoarthritis (OA). We aimed to characterize the role of the clock gene in OA-induced pain more systemically using both genetic and pharmacological approaches. Genetically modified mice, (bmal1f/fNav1.

View Article and Find Full Text PDF

Discogenic low back pain (DLBP) is extremely common and costly. Effective treatments are lacking due to DLBP's unknown pathogenesis. Currently, there are no in vivo mouse models of DLBP, which restricts research in this field.

View Article and Find Full Text PDF

Genome wide studies indicate that vascular endothelial growth factor A (VEGF) is associated with osteoarthritis (OA), and increased VEGF expression correlates with increased disease severity. VEGF is also a chondrocyte survival factor during development and essential for bone formation, skeletal growth and postnatal homeostasis. This raises questions of how the important embryonic and postnatal functions of VEGF can be reconciled with an apparently destructive role in OA.

View Article and Find Full Text PDF

Chronic low back pain is a major cause of disability and health care costs. Effective treatments are inadequate for many patients. Animal models are essential to further understanding of the pain mechanism and testing potential therapies.

View Article and Find Full Text PDF